Developer docs
API playgroundTry for free, no card

Search company profiles

Noshaq

Full company profile

uuid0003bqx

Namestring
Noshaq
Legal namestring
NOSHAQ S.A.
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Noshaq is a Liège-based private investment fund structured as a Belgian Société Anonyme, founded in 1985 as Meusinvest to drive industrial reconversion of the Liège region following the steel crisis and rebranded to Noshaq in 2016. The firm provides financing solutions and ecosystem development services to SMEs headquartered in the province of Liège, deploying an average of €120 million annually across a portfolio of 478 companies spanning seven priority sectors: Life Sciences, Digital/Numeric, Industry 4.0, Real Estate & Conversion, Agri-food, Cultural & Creative Industries, and Energy & Sustainable Development.

Noshaq's core offering consists of three integrated service lines: funding solutions (minority equity capital, convertible and secured/unsecured bonds, and equipment/real estate leasing), strategic project structuring (purpose-built infrastructure including the 30,000m² LégiaPark life sciences center and 8,000m² La Grand Poste creative hub), and portfolio management with active board participation. The fund holds minority stakes with predetermined buy-back terms, enabling portfolio companies to reclaim equity over time. Its revenue model combines investment returns from equity appreciation, recurring interest income from loan products, leasing income from financial contracts, and management fees on ecosystem projects.

The go-to-market approach is relationship-driven and ecosystem-mediated, with deal flow sourced through direct outreach by a 60-person investment team and a referral network spanning academic institutions (University of Liège, GIGA biomedical institute with 600+ scientists), support organizations (Eklo, B2H, Interface-Gesval), and co-investors (BNP Paribas, Bpifrance, Crédit Mutuel Innovation, Innovacom, FUND+). Distribution is constrained geographically to Liège-province-headquartered companies, but portfolio companies like LIFEPOWR and Mycophyto expand internationally. Noshaq operates through wholly-owned subsidiaries including LeanSquare (digital/startup fund, €13M+ deployed across 65+ startups since 2014), Noshaq Immo (real estate), Noshaq Spin-Offs (university spin-out fund), and Noshaq Venture (early-stage VC). The firm completed a historic €133 million fundraising in 2021 to execute its 2021-2026 strategic plan.

Short descriptiontext

Noshaq is a Liège-based private investment fund (founded 1985, rebranded 2016) that provides minority equity, loans, and leasing to 478 SMEs across 7 priority sectors in Belgium's Liège province, supported by €133M raised in 2021 and €120M average annual deployment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLiège, Belgium
HQ citystring
Liège
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regional investment fund, SME financing solutions, venture capital, equity investment, ecosystem development
NAICS code1 code
  • Securities, Commodity Contracts, and Other Financial Investments and Related Activities523
SIC code1 code
  • Security & Commodity Brokers, Dealers, Exchanges & Services6200
Product category
Regional Investment Fund / Venture Capital
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Equity Investment Returns
TypeSubscription Recurring
Description

Noshaq acquires minority stakes in companies and generates returns through capital appreciation and eventual exit when shareholders buy back shares at predetermined prices.

noshaq.be
2Loan Interest Income
TypeSubscription Recurring
Description

Noshaq provides various loan products including convertible bonds, secured and unsecured bonds, generating interest income.

noshaq.be
3Leasing and Financial Lease Contracts
TypeSubscription Recurring
Description

Equipment and real estate leasing arrangements providing recurring lease income.

noshaq.be
4Strategic Project Development
TypeManaged Services
Description

Development and management of strategic infrastructure projects (LégiaPark, La Grand Poste) that support portfolio companies and generate returns.

noshaq.be
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
Pricing details1 tier
1Customized financing solutions negotiated per company
ModelOtherBilling cadenceMulti-year contract
Notes

Noshaq offers a wide choice of complementary interventions including capital injection (minority stake), various loan products (convertible bonds, secured/unsecured bonds), and leasing contracts for equipment or real estate. Terms are customized based on company needs and situation.

noshaq.be
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Noshaq is a Liège-based investment fund that provides financing solutions and strategic support to small and medium enterprises in the province of Liège, Belgium. Its core offering consists of capital injection through minority equity stakes, loans (convertible and non-convertible bonds with or without security), equipment and real estate leasing, and the structuring of strategic ecosystem projects such as LégiaPark and La Grand Poste. The fund manages a portfolio of 478 companies across 7 priority sectors, deploying an average of €120 million annually.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4,000+ direct jobs created in Life Sciences sector
+4 more records
Product overview1 text field

Noshaq is a Liège-based investment fund offering a unified portfolio of financing and support services for businesses. The core offering consists of funding solutions (capital injection, loans, leasing), strategic project structuring, and portfolio management across 7 priority sectors. The fund has developed an internal product called Qairn, a free electronic business card application for smartphones, entirely developed by Noshaq's internal teams. The portfolio spans 478 companies including life sciences, digital/IT, Industry 4.0, real estate, agro-food, cultural industries, and energy sectors.

Product and service4 records
1Funding Solutions
CategoryInvestment Financing
Description

Complementary financing solutions for SMEs including capital injection through minority stake acquisition, loans (convertible and non-convertible bonds with or without security), and equipment/real estate leasing contracts. Investment terms are customized and negotiated directly with the Noshaq team, targeting companies headquartered in Liège province.

2Structuring Strategic Projects
CategoryStrategic Infrastructure Development
Description

Strategic project development supporting SMEs and the Liège economy through infrastructure initiatives such as LégiaPark (30,000m² life sciences business centre), La Grand Poste (creative district hub), and partnerships with GIGA research institute, WSL engineering support, and Pôle Image de Liège audiovisual federation.

3Investment Portfolio Management
CategoryPortfolio Management
Description

Active management of a portfolio of 478 companies across 7 strategic sectors: Life Sciences, Digital/Numerical, Industry 4.0, Real Estate & Conversion, Agri-food, Cultural Industries, and Energy & Sustainable Development. Includes board representation, strategic guidance, and exit management via share buybacks at predetermined prices.

4Qairn Electronic Business Cards
CategoryDigital Tools
Description

Qairn is a free smartphone application developed internally by Noshaq that allows users to create customizable electronic business cards with just two clicks.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership18 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

B2H is a key strategic partner in the Life Sciences ecosystem. The partnership provides comprehensive support for biotech and healthcare companies including financing, sector expertise, and acceleration services. Noshaq and B2H work together to position Liège internationally in the life sciences sector.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Eklo provides startup support and acceleration services. As Noshaq's 'accompagnement' (support) branch launched in 2009, Eklo helps identify and develop promising projects for potential Noshaq investment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The GIGA is an interdisciplinary biomedical research institute with 600+ scientists at the University of Liège. The partnership provides access to cutting-edge research, talent pipeline, and spin-off opportunities for Noshaq's life sciences portfolio.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WSL supports Walloon engineering projects by providing expertise and infrastructure. The partnership enables Noshaq to identify and support techno-entrepreneurs in the industry sector throughout their company lifecycle.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Technology transfer interface between academic research and commercial applications, helping to identify and prepare promising research projects for investment consideration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

A 30,000m² business centre dedicated to life sciences companies, located opposite Mont-Légia hospital. LégiaPark offers turnkey premises (offices, labs, clean rooms, logistics areas) developed by Noshaq to support the biotech/biopharma ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

An 8,000m² creative hub in Liège's Grand Leopold district housing entrepreneurs in digital, media, and entertainment. Features co-working, food market, craft brewery, startup programs, and journalism media campus. Serves as the totem of the creative district.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Noshaq's specialized investment fund focused on digital, creative, and life sciences startups. LeanSquare has invested €13M+ across 65+ startups since 2014, operating programs including Wallifornia Musictech and SportsTech Belgium.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Federation of audiovisual service providers covering cinema, broadcast, and corporate markets. Noshaq supports the industry through adapted infrastructure and financial incentives, including Tax Shelter provisions.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Producer of substrates and mushrooms. Portfolio company representing Noshaq's involvement in sustainable agriculture and food innovation sector.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Company producing agricultural fertilizers from human urine valorization. Represents Noshaq's commitment to circular economy and sustainable agriculture innovation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Indoor shrimp farming company with heat recovery capabilities. Portfolio company in sustainable food production sector.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

French algaebiorefinery company producing egg substitutes and other food ingredients from microalgae. Noshaq participated in their 2022 financing round and facilitates industrial partnerships (e.g., with Castle Ingredients in Belgium).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Belgian partner in Eupen specialized in industrial processes and plant-based ingredients. Noshaq facilitated the partnership between Castle Ingredients and Algama for scaling algae ingredient production.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Belgian biotech company at LégiaPark developing injectable hydrogel implants for osteoarthritis treatment. Noshaq is an investor and provides ecosystem support through the life sciences network.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Liège-based company specializing in plasma and supersonic coating of metals, alloys, ceramics, and carbides on mechanical parts. Represents Noshaq's Industry 4.0 expertise and international industrial connections.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Liège-based IT services company with ~1,900 employees across Belgium, France, Canada, and Luxembourg. Expected 2025 revenue of €270M. Supported by Noshaq and Cegeka as shareholders.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Open-source ERP/CRM software company headquartered in Belgium. Represents the success story of the Walloon tech ecosystem that Noshaq helps cultivate.

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Walloon regional investment fund providing equity and loan financing to SMEs in Wallonia. Highly comparable in mission, regional mandate, financing instruments, and sectoral development focus — operates as Noshaq's primary public-sector counterpart in the broader Wallonia region.

TypeDirect peer
Description

Regional investment fund focused on Charleroi/Sambre area SMEs with similar equity/loan products and active board participation model. Closest analogue to Noshaq in terms of regional mandate and SME-focused development investing.

TypeBroad incumbent
Description

Belgium's leading listed private equity and venture capital firm, operating across multiple regions and sectors. Comparable as a Belgian institutional investor in growth-stage SMEs, though broader in geographic scope and substantially larger in scale.

TypeBroad incumbent
Description

Belgian investment holding company with diversified PE/VC and growth equity exposure. Comparable as a Belgian institutional investor with similar portfolio diversification and long-duration capital, though operating nationally and globally rather than regionally.

TypeDirect peer
Description

Flemish regional investment fund supporting SMEs in Limburg with equity, loans, and infrastructure. Strong analogue as a Belgian regional development investor with an industrial reconversion heritage, similar product suite, and ecosystem-building approach.

TypeBroad incumbent
Description

French public investment bank providing financing across the full SME lifecycle. Comparable as a frequent co-investor in Noshaq's portfolio (Standing Ovation, Mycophyto), though operating at vastly greater scale and across France rather than regionally.

TypeBroad incumbent
Description

Belgian federal holding company managing state shareholdings and strategic investments. Comparable as a Belgian public investor with cross-sector investment exposure, though at federal level rather than provincial.

TypeDirect peer
Description

Belgian independent venture capital and growth equity firm with multi-sector tech and life sciences focus. Comparable as a Belgian institutional investor backing innovation-driven SMEs, particularly in the same life sciences and digital verticals.

TypeDirect peer
Description

Walloon venture capital fund focused on spin-offs and early-stage innovation. Comparable as a Walloon-based PE/VC with similar university spin-off pipeline exposure (particularly from ULiège ecosystem) and minority equity participation model.

TypeDirect peer
Description

Flemish regional investment company providing equity, loans, and infrastructure support to Flemish SMEs. Highly comparable as a Belgian regional development investor with ecosystem-building mandate, equivalent products, and similar sectoral specialization.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment9 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment16 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Noshaq

Regional Investment Fund / Venture Capitalnoshaq.be/en

Noshaq is a Liège-based private investment fund (founded 1985, rebranded 2016) that provides minority equity, loans, and leasing to 478 SMEs across 7 priority sectors in Belgium's Liège province, supported by €133M raised in 2021 and €120M average annual deployment.

What Noshaq does

Noshaq is a Liège-based private investment fund structured as a Belgian Société Anonyme, founded in 1985 as Meusinvest to drive industrial reconversion of the Liège region following the steel crisis and rebranded to Noshaq in 2016. The firm provides financing solutions and ecosystem development services to SMEs headquartered in the province of Liège, deploying an average of €120 million annually across a portfolio of 478 companies spanning seven priority sectors: Life Sciences, Digital/Numeric, Industry 4.0, Real Estate & Conversion, Agri-food, Cultural & Creative Industries, and Energy & Sustainable Development.

Noshaq's core offering consists of three integrated service lines: funding solutions (minority equity capital, convertible and secured/unsecured bonds, and equipment/real estate leasing), strategic project structuring (purpose-built infrastructure including the 30,000m² LégiaPark life sciences center and 8,000m² La Grand Poste creative hub), and portfolio management with active board participation. The fund holds minority stakes with predetermined buy-back terms, enabling portfolio companies to reclaim equity over time. Its revenue model combines investment returns from equity appreciation, recurring interest income from loan products, leasing income from financial contracts, and management fees on ecosystem projects.

The go-to-market approach is relationship-driven and ecosystem-mediated, with deal flow sourced through direct outreach by a 60-person investment team and a referral network spanning academic institutions (University of Liège, GIGA biomedical institute with 600+ scientists), support organizations (Eklo, B2H, Interface-Gesval), and co-investors (BNP Paribas, Bpifrance, Crédit Mutuel Innovation, Innovacom, FUND+). Distribution is constrained geographically to Liège-province-headquartered companies, but portfolio companies like LIFEPOWR and Mycophyto expand internationally. Noshaq operates through wholly-owned subsidiaries including LeanSquare (digital/startup fund, €13M+ deployed across 65+ startups since 2014), Noshaq Immo (real estate), Noshaq Spin-Offs (university spin-out fund), and Noshaq Venture (early-stage VC). The firm completed a historic €133 million fundraising in 2021 to execute its 2021-2026 strategic plan.

Noshaq firmographics

Firmographics
Name
Noshaq
Legal name
NOSHAQ S.A.
Website
https://noshaq.be/en
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Short description
Noshaq is a Liège-based private investment fund (founded 1985, rebranded 2016) that provides minority equity, loans, and leasing to 478 SMEs across 7 priority sectors in Belgium's Liège province, supported by €133M raised in 2021 and €120M average annual deployment.
Ownership category
akta.pro rank

Where Noshaq is headquartered

Location

Headquarters

HQ city
Liège
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Noshaq business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Equity Investment Returns: Noshaq acquires minority stakes in companies and generates returns through capital appreciation and eventual exit when shareholders buy back shares at predetermined prices.
  2. Loan Interest Income: Noshaq provides various loan products including convertible bonds, secured and unsecured bonds, generating interest income.
  3. Leasing and Financial Lease Contracts: Equipment and real estate leasing arrangements providing recurring lease income.
  4. Strategic Project Development: Development and management of strategic infrastructure projects (LégiaPark, La Grand Poste) that support portfolio companies and generate returns.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustomized financing solutions negotiated per company

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Noshaq product offering

Product offering

Core offering

Noshaq is a Liège-based investment fund that provides financing solutions and strategic support to small and medium enterprises in the province of Liège, Belgium. Its core offering consists of capital injection through minority equity stakes, loans (convertible and non-convertible bonds with or without security), equipment and real estate leasing, and the structuring of strategic ecosystem projects such as LégiaPark and La Grand Poste. The fund manages a portfolio of 478 companies across 7 priority sectors, deploying an average of €120 million annually.

Product overview

Noshaq is a Liège-based investment fund offering a unified portfolio of financing and support services for businesses. The core offering consists of funding solutions (capital injection, loans, leasing), strategic project structuring, and portfolio management across 7 priority sectors. The fund has developed an internal product called Qairn, a free electronic business card application for smartphones, entirely developed by Noshaq's internal teams. The portfolio spans 478 companies including life sciences, digital/IT, Industry 4.0, real estate, agro-food, cultural industries, and energy sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Funding Solutions Complementary financing solutions for SMEs including capital injection through minority stake acquisition, loans (convertible and non-convertible bonds with or without security), and equipment/real estate leasing contracts. Investment terms are customized and negotiated directly with the Noshaq team, targeting companies headquartered in Liège province.
  • Structuring Strategic Projects Strategic project development supporting SMEs and the Liège economy through infrastructure initiatives such as LégiaPark (30,000m² life sciences business centre), La Grand Poste (creative district hub), and partnerships with GIGA research institute, WSL engineering support, and Pôle Image de Liège audiovisual federation.
  • Investment Portfolio Management Active management of a portfolio of 478 companies across 7 strategic sectors: Life Sciences, Digital/Numerical, Industry 4.0, Real Estate & Conversion, Agri-food, Cultural Industries, and Energy & Sustainable Development. Includes board representation, strategic guidance, and exit management via share buybacks at predetermined prices.
  • Qairn Electronic Business Cards Qairn is a free smartphone application developed internally by Noshaq that allows users to create customizable electronic business cards with just two clicks.

Quantifiable outcome

  • 4,000+ direct jobs created in Life Sciences sector
  • +4 more outcomes

Companies that use Noshaq

Customer profile

Named customers3 records

Segments9 records

Ideal customer profiles3 records

Noshaq technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Noshaq partnerships and signals

Strategic signal

Partnerships

18 partnerships are on record, tiered core and minor.

  • B2H (Bridge to Health)coreStrategic or Co-development Partner · 1 January 2021B2H is a key strategic partner in the Life Sciences ecosystem. The partnership provides comprehensive support for biotech and healthcare companies including financing, sector expertise, and acceleration services. Noshaq and B2H work together to position Liège internationally in the life sciences sector.
  • Eklo (formerly Cide-Socran)coreStrategic or Co-development PartnerEklo provides startup support and acceleration services. As Noshaq's 'accompagnement' (support) branch launched in 2009, Eklo helps identify and develop promising projects for potential Noshaq investment.
  • GIGA (Université de Liège)coreStrategic or Co-development PartnerThe GIGA is an interdisciplinary biomedical research institute with 600+ scientists at the University of Liège. The partnership provides access to cutting-edge research, talent pipeline, and spin-off opportunities for Noshaq's life sciences portfolio.
  • WSL (Walloon Space for Leadership)coreStrategic or Co-development PartnerWSL supports Walloon engineering projects by providing expertise and infrastructure. The partnership enables Noshaq to identify and support techno-entrepreneurs in the industry sector throughout their company lifecycle.
  • Interface-GesvalminorImplementation/ SI/ Consulting PartnerTechnology transfer interface between academic research and commercial applications, helping to identify and prepare promising research projects for investment consideration.
  • LégiaParkcoreStrategic or Co-development PartnerA 30,000m² business centre dedicated to life sciences companies, located opposite Mont-Légia hospital. LégiaPark offers turnkey premises (offices, labs, clean rooms, logistics areas) developed by Noshaq to support the biotech/biopharma ecosystem.
  • La Grand PostecoreStrategic or Co-development PartnerAn 8,000m² creative hub in Liège's Grand Leopold district housing entrepreneurs in digital, media, and entertainment. Features co-working, food market, craft brewery, startup programs, and journalism media campus. Serves as the totem of the creative district.
  • LeanSquarecoreStrategic or Co-development PartnerNoshaq's specialized investment fund focused on digital, creative, and life sciences startups. LeanSquare has invested €13M+ across 65+ startups since 2014, operating programs including Wallifornia Musictech and SportsTech Belgium.
  • Pôle Image de LiègeminorStrategic or Co-development PartnerFederation of audiovisual service providers covering cinema, broadcast, and corporate markets. Noshaq supports the industry through adapted infrastructure and financial incentives, including Tax Shelter provisions.
  • ECLOminorStrategic or Co-development PartnerProducer of substrates and mushrooms. Portfolio company representing Noshaq's involvement in sustainable agriculture and food innovation sector.
  • TOOPI OrganicsminorStrategic or Co-development PartnerCompany producing agricultural fertilizers from human urine valorization. Represents Noshaq's commitment to circular economy and sustainable agriculture innovation.
  • LISAQUAminorStrategic or Co-development PartnerIndoor shrimp farming company with heat recovery capabilities. Portfolio company in sustainable food production sector.
  • AlgamaminorStrategic or Co-development PartnerFrench algaebiorefinery company producing egg substitutes and other food ingredients from microalgae. Noshaq participated in their 2022 financing round and facilitates industrial partnerships (e.g., with Castle Ingredients in Belgium).
  • Castle IngredientsminorStrategic or Co-development PartnerBelgian partner in Eupen specialized in industrial processes and plant-based ingredients. Noshaq facilitated the partnership between Castle Ingredients and Algama for scaling algae ingredient production.
  • AllegrominorStrategic or Co-development PartnerBelgian biotech company at LégiaPark developing injectable hydrogel implants for osteoarthritis treatment. Noshaq is an investor and provides ecosystem support through the life sciences network.
  • Advanced CoatingminorStrategic or Co-development PartnerLiège-based company specializing in plasma and supersonic coating of metals, alloys, ceramics, and carbides on mechanical parts. Represents Noshaq's Industry 4.0 expertise and international industrial connections.
  • NSI IT Software & ServicescoreStrategic or Co-development PartnerLiège-based IT services company with ~1,900 employees across Belgium, France, Canada, and Luxembourg. Expected 2025 revenue of €270M. Supported by Noshaq and Cegeka as shareholders.
  • OdoominorStrategic or Co-development PartnerOpen-source ERP/CRM software company headquartered in Belgium. Represents the success story of the Walloon tech ecosystem that Noshaq helps cultivate.

Scale indicators7 records

Recent moves10 records

Expansion highlights5 records

Noshaq competitors and assessment

Company assessment

Direct peers

  • SRIW (Société Régionale d'Investissement de Wallonie): Walloon regional investment fund providing equity and loan financing to SMEs in Wallonia. Highly comparable in mission, regional mandate, financing instruments, and sectoral development focus — operates as Noshaq's primary public-sector counterpart in the broader Wallonia region.
  • Sambrinvest: Regional investment fund focused on Charleroi/Sambre area SMEs with similar equity/loan products and active board participation model. Closest analogue to Noshaq in terms of regional mandate and SME-focused development investing.
  • LRM (Limburgse Reconversie Maatschappij): Flemish regional investment fund supporting SMEs in Limburg with equity, loans, and infrastructure. Strong analogue as a Belgian regional development investor with an industrial reconversion heritage, similar product suite, and ecosystem-building approach.
  • Capricorn Partners: Belgian independent venture capital and growth equity firm with multi-sector tech and life sciences focus. Comparable as a Belgian institutional investor backing innovation-driven SMEs, particularly in the same life sciences and digital verticals.
  • Nivelinvest: Walloon venture capital fund focused on spin-offs and early-stage innovation. Comparable as a Walloon-based PE/VC with similar university spin-off pipeline exposure (particularly from ULiège ecosystem) and minority equity participation model.
  • PMV (Participatiemaatschappij Vlaanderen): Flemish regional investment company providing equity, loans, and infrastructure support to Flemish SMEs. Highly comparable as a Belgian regional development investor with ecosystem-building mandate, equivalent products, and similar sectoral specialization.

Broad incumbents

  • Gimv: Belgium's leading listed private equity and venture capital firm, operating across multiple regions and sectors. Comparable as a Belgian institutional investor in growth-stage SMEs, though broader in geographic scope and substantially larger in scale.
  • Sofina: Belgian investment holding company with diversified PE/VC and growth equity exposure. Comparable as a Belgian institutional investor with similar portfolio diversification and long-duration capital, though operating nationally and globally rather than regionally.
  • Bpifrance: French public investment bank providing financing across the full SME lifecycle. Comparable as a frequent co-investor in Noshaq's portfolio (Standing Ovation, Mycophyto), though operating at vastly greater scale and across France rather than regionally.
  • SFPI-FPIM (Société Fédérale de Participations et d'Investissement): Belgian federal holding company managing state shareholdings and strategic investments. Comparable as a Belgian public investor with cross-sector investment exposure, though at federal level rather than provincial.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Noshaq social profiles

Digital presence

Noshaq financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Noshaq leadership team

Management profile

Number of profiles

Profiles11 records

Noshaq subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Noshaq funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Noshaq M&A and investment

M&A and investment

M&A

Investments16 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noshaq

What does Noshaq do?

Noshaq is a Liège-based investment fund that provides financing solutions and strategic support to small and medium enterprises in the province of Liège, Belgium. Its core offering consists of capital injection through minority equity stakes, loans (convertible and non-convertible bonds with or without security), equipment and real estate leasing, and the structuring of strategic ecosystem projects such as LégiaPark and La Grand Poste. The fund manages a portfolio of 478 companies across 7 priority sectors, deploying an average of €120 million annually.

Is Noshaq a public or private company?

Noshaq is a private company. It is classified as unknown and is currently operating.

When was Noshaq founded?

Noshaq was founded in 1985. It employs 11 to 50 people.

Where is Noshaq based?

Noshaq is headquartered in Liège, Belgium, in the Europe region.

How does Noshaq make money?

Four revenue lines are on record. Equity Investment Returns are the primary driver. The others are loan Interest Income, leasing and Financial Lease Contracts and strategic Project Development.

Who are Noshaq's main competitors?

Direct peers on record are SRIW (Société Régionale d'Investissement de Wallonie), Sambrinvest, LRM (Limburgse Reconversie Maatschappij), Capricorn Partners, Nivelinvest and PMV (Participatiemaatschappij Vlaanderen). Broad incumbents are Gimv, Sofina, Bpifrance and SFPI-FPIM (Société Fédérale de Participations et d'Investissement).

Does Noshaq have an API?

No public API is recorded for Noshaq.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartupmafiaBelgium’s Novadip Biosciences Raises €10.4M to Fund Pivotal Clinical Trial and Unlock EIB Loan TrancheNovadip Biosciences closed a €10.4 million convertible financing round led by New Science Ventures, bringing total convertible financing to €20 million since June 2025. The funds will support completion of a pivotal Phase 3 trial of NVD003 for congenital pseudarthrosis of the tibia and prepare for a US BLA. The company aims to obtain market authorization by 2028.European BiotechnologyBrenus adds €11M to colorectal cancer vaccine developmentBrenus Pharma raised an €11 million Series A extension to complete Phase 1 development of its colorectal cancer vaccine STC-1010. The funding brings the Series A to €33.2 million, with new investors including Sambrinvest and Omega Investment Corp. Proceeds will advance the next drug candidate.FinSMEsBrenus Pharma Raises €11M in Series A Extension FundingBrenus Pharma, a Lyon-based immuno-oncology platform developer, raised €11M in Series A extension funding from Angelor, UI Investissement, and others. The round brings total funding to €38M, which the company will use to expand operations and R&D efforts.BioSpaceBrenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A ExtensionBrenus Pharma announced an €11 million extension to its Series A round, bringing total capital raised to €38 million. The funding supports its lead clinical-stage in-vivo immunotherapy STC-1010 for MSS mCRC and welcomes new investors from Europe and Asia-Pacific.LisaquaLow-Impact & Sustainable AquacultureLisaqua, a French sustainable shrimp farming company founded in 2018, raised €9 million in a capital increase led by the Révolution Environnementale et Solidaire Fund managed by Crédit Mutuel Impact, with participation from Belgian fund Noshaq and historical investors Le Gouessant and Mer Invest. The funding will enable Lisaqua to develop an industrial farm with a capacity of 100 tonnes of shrimp in Monthyon (Seine-et-Marne) and pursue commercial development and R&D. The company has developed patented land-based farming technology that produces shrimp without antibiotics or sulfites, using circular economy techniques including waste heat recovery and water reuse, supported by the French government program "Première Usine" under France 2030.LinkedIn#fundraising #ardent #teamGet Your Way has closed its second fundraising round, securing €850,000 in investment from partners Industrya and Noshaq. The capital will be used to deploy the company's aRdent solutions more widely across various industries.GlobeNewswireHEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Foundation Fournier-Majoie and NoshaqHEPHAISTOS-Pharma secured a €2 million seed funding round led by xista science ventures and the Foundation Fournier-Majoie, with participation from Noshaq. The capital will finance GMP transfer and clinical advancement of its lead candidate, ONCO-Boost, a TLR4 immunostimulant for treating solid tumors like sarcoma. Additionally, HEPHAISTOS-Pharma plans to open a new subsidiary in Liège, Wallonia, to leverage local facilities for pipeline expansion.The European Life Sciences Web PortalAmyl Therapeutics–Noshaq: investment, 202106 financing round Series A totalling €8.6m incl lead investor NoshaqAmyl Therapeutics successfully closed a €18.3 million Series A financing round on June 3, 2021, with €8.6 million raised in equity led by Noshaq. The funds will be utilized to advance its ClariTY technology platform, which aims to develop therapies for Amyloidosis, affecting a significant number of patients in the USA and Europe. This financing positions Amyl Therapeutics to potentially establish a competitive edge in treating these rare diseases.